Author Archives: Jon Jay


Coca-Cola Helps the Global Fund Deliver Medicines: A Look at the Ethics of Public-Private Partnerships


In the Institute’s last blog posting, Tanya Baytor commented on how large manufacturers of unhealthy foods, including Coca-Cola, McDonald’s and Cadbury’s, took advantage of the Olympics to associate their products with health.  Tanya raised the concern that these companies’ exclusive Olympic sponsorship deals helped them market to children, a segment of the population which is […]

Posted in Global Health, uncategorized ;


PrEP News: FDA Approves First Drug for HIV Prevention


The Food and Drug Administration announced today its approval of tenofovir-emtricitabine (aka Truvada) for HIV prevention.  Truvada, which has been approved since 2004 for use in HIV treatment, is now approved for use as preexposure prophylaxis (“PrEP”)–a strategy in which an HIV-negative person uses an antiretroviral drug (in this case a daily pill) to reduce […]

Posted in uncategorized ;


A Bad News Week for Women and HIV Prevention–and What's Next


It started Wednesday, Sept. 28 when the Microbicide Trials Network—a clinical trials network funded by the U.S. National Institutes of Health (NIH)—announced that one arm of its VOICE study was being discontinued for futility.  VOICE follows 5000 sexually active, HIV-negative women in Uganda, South Africa and Zimbabwe, testing the safety and effectiveness of HIV prevention […]

Posted in uncategorized ;

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.